immune system
• the anti-bacterial activity of macrophages is impaired in these mice
• bone-marrow derived macrophages pre-treated with IFN-gamma have higher intracellular titers of Listeria monocytogenes 3 and 6 hours after in vitro infection
• titers are lower than those found in macrophages from Stat1tm1Dlv homozygotes
|
• there are no high expressers of class II among a population of bone marrow derived macrophages
|
• only 9% of mice die within 70 hours of 25 mg/kg body weight of LPS administration while 46% of wild-type mice die within 46 hours
• 80% of mice die at a dose of 37 mg/kg body weight of LPS but with a significant delay compared to wild-type mice
|
• only 80% of the mice survive when infected with 105 Listeria monocytogenes bacteria while all wild-type mice survive
• all mice die when infected with 106 L. monocytogenes bacteria while 80% of wild-type mice survive
• clearance of L. monocytogenes bacteria from the spleen and liver is reduced by 10-fold compared to wild-type mice 3 days after infection
|
• primary fibroblasts need to be pre-treated with higher doses of IFN-gamma than wild-type fibroblasts do to survive exposure to vesicular stomatitis for 24 hours
• this partial protection is better than observed in fibroblasts from Stat1tm1Dlv homozygotes
|
hematopoietic system
• the anti-bacterial activity of macrophages is impaired in these mice
• bone-marrow derived macrophages pre-treated with IFN-gamma have higher intracellular titers of Listeria monocytogenes 3 and 6 hours after in vitro infection
• titers are lower than those found in macrophages from Stat1tm1Dlv homozygotes
|
• there are no high expressers of class II among a population of bone marrow derived macrophages
|